| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11325-010-0408-6 |
| P698 | PubMed publication ID | 20872181 |
| P50 | author | Demosthenes Bouros | Q54130810 |
| Christos T. Nakas | Q40671664 | ||
| P2093 | author name string | Christos Liavvas | |
| Emmanuel G Vlachogiannis | |||
| Euphemia G Daskalopoulou | |||
| Nicholas V Dombros | |||
| P2860 | cites work | Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia. | Q53245292 |
| Nocturnal urinary protein excretion rates in patients with sleep apnea | Q69944517 | ||
| Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects | Q74800730 | ||
| Impaired diurnal blood pressure variation and all-cause mortality | Q80228526 | ||
| The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 | ||
| Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study | Q29615583 | ||
| Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement | Q33543161 | ||
| Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure | Q34180371 | ||
| Microalbuminuria: what is it? Why is it important? What should be done about it? | Q34287788 | ||
| Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome | Q34734265 | ||
| Obstructive sleep apnoea and its cardiovascular consequences | Q34909223 | ||
| Obstructive sleep apnoea syndrome--an oxidative stress disorder | Q35066278 | ||
| Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? | Q35918647 | ||
| Obstructive sleep apnea is associated with increased urinary albumin excretion. | Q35995542 | ||
| Sleep apnea is a manifestation of the metabolic syndrome | Q36127164 | ||
| Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA) | Q36528602 | ||
| Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects | Q42249870 | ||
| Do patients with obstructive sleep apnea have clinically significant proteinuria? | Q43584469 | ||
| Proteinuria in obstructive sleep apnea | Q43750350 | ||
| An aid to the early detection and management of diabetic nephropathy: assessment of a new point of care microalbuminuria system in the diabetic clinic | Q43795801 | ||
| Impact of abnormal nocturnal blood pressure fall on vascular function | Q44350144 | ||
| Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients | Q44773562 | ||
| Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. | Q44931989 | ||
| Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study | Q45048798 | ||
| Multiple biomarkers and the risk of incident hypertension | Q45179922 | ||
| Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study | Q45181167 | ||
| Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea | Q46460378 | ||
| The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in nondiabetic persons. | Q46485534 | ||
| Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis | Q46546982 | ||
| Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects | Q46689532 | ||
| Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing | Q48022686 | ||
| Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives | Q48284811 | ||
| Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea | Q48439260 | ||
| Early signs of atherosclerosis in obstructive sleep apnea | Q48551584 | ||
| Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome | Q48634954 | ||
| Circadian rhythm of glomerular filtration rate in normal individuals | Q48940606 | ||
| High ventilatory response to hypoxia in hypertensive patients with sleep apnea | Q48948174 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 589-597 | |
| P577 | publication date | 2010-09-25 | |
| P1433 | published in | Sleep and Breathing | Q15762247 |
| P1476 | title | Obstructive sleep apnoea syndrome promotes reversal albuminuria during sleep | |
| P478 | volume | 15 |
| Q39757312 | Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study |
| Q48093775 | Does CPAP therapy alter urinary albumin level in adult patients with moderate to severe obstructive sleep apnea syndrome? |
| Q39720560 | Effect of continuous positive airway pressure on proteinuria in obstructive sleep apnea. |
| Q43900914 | Functional gastrointestinal disorders among adolescents with poor sleep: a school-based study in Shanghai, China |
| Q48207131 | Low-grade albuminuria in children with obstructive sleep apnea |
| Q39929396 | Microalbuminuria in Patients with Obstructive Sleep Apnea-Chronic Obstructive Pulmonary Disease Overlap Syndrome |
| Q53833867 | Obstructive sleep apnea and chronic kidney disease: open questions on a potential public health problem. |
| Q38112518 | The biological consequence of obesity on the kidney |
Search more.